Sex hormone levels and risk of breast cancer with estrogen plus progestin. Read more about Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Cancer incidence trends among native Hawaiians and other Pacific Islanders in the United States, 1990-2008. Read more about Cancer incidence trends among native Hawaiians and other Pacific Islanders in the United States, 1990-2008.
Cancer incidence trends among Asian American populations in the United States, 1990-2008. Read more about Cancer incidence trends among Asian American populations in the United States, 1990-2008.
Benign breast disease, mammographic breast density, and the risk of breast cancer. Read more about Benign breast disease, mammographic breast density, and the risk of breast cancer.
Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. Read more about Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. Read more about A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. Read more about Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2. Read more about Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. Read more about Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? Read more about Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
